Lobbying Affiliate: MML&K Government Solutions
{ Banner Image }

Healthcare Law Blog

Comprehensive Healthcare law services.
It's kind of our bag.

Contact Us

250 Character(s) Remaining
Type the following characters: november, hotel, niner, papa, foxtrot, tango

* Indicates a required field.

Categories

McBrayer Blogs

Related Blogs

Showing 3 posts in Drug Enforcement Agency ("DEA").

DEA Proposes New Tele-Prescribing Rules for End of COVID-19 State of Emergency

Posted In COVID-19, Drug Enforcement Agency ("DEA"), Prescription Drugs, Telehealth, Telemedicine

At the end of January, the Biden Administration announced that May 11, 2023, would mark the end of the federal public health emergency (PHE) declarations that have been in place for the last three years. For healthcare providers, this means change is on the horizon, especially where telemedicine is concerned. In response to the impending end of emergency telehealth provisions, the Drug Enforcement Agency (DEA) has proposed a permanent rule regarding the prescription of controlled medications via telemedicine in order to extend COVID-era accommodations. The public will be able to comment for 30 days on the proposed rules. A summary of the rules can be found here: Proposed Telemedicine Rules Summary. More >

Voluntary Surrender of DEA Registration: Proceed With Caution

Posted In Agreed Order, Drug Enforcement Agency ("DEA"), Kentucky Board of Medical Licensure, Licensure Requirements

All too often, the Drug Enforcement Agency (“DEA”) asks a physician to surrender his or her DEA registration when the physician enters into a prescribing-related Agreed Order with the applicable state licensing authority. A DEA registration is important because, in order to write prescriptions for controlled substances or dispense controlled substances in-office, physicians must be registered with the DEA. More >

Lexington, KYLouisville, KYFrankfort, KYFrankfort, KY: MML&K Government Solutions